ADMA
ADMA Biologics Inc
NASDAQ: ADMA · HEALTHCARE · BIOTECHNOLOGY
$10.60
-2.75% today
Updated 2026-04-29
Market cap
$2.46B
P/E ratio
17.67
P/S ratio
4.83x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$7 – $24
Volume
6.8M
ADMA Biologics Inc (ADMA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-4.0%
Last 4 quarters
Revenue YoY growth
+18.4%
Most recent quarter
EPS YoY growth
+58.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.5%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-11.7%
2025-08-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $0.22 | +15.5% | $14.87 | $14.32 | -3.7% |
| 2025-11-05 | $0.15 | +0.0% | $14.63 | $14.03 | -4.1% |
| 2025-08-06 | $0.14 | -6.7% | $18.96 | $16.75 | -11.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.19 | $0.22 | +15.5% | $139.16M | +18.4% |
| 2025-09-30 | $0.15 | $0.15 | +0.0% | $134.22M | +12.0% |
| 2025-06-30 | $0.15 | $0.14 | -6.7% | $121.98M | +13.8% |
| 2025-03-31 | $0.15 | $0.11 | -25.0% | $114.80M | +40.2% |
| 2024-12-31 | $0.15 | $0.14 | -6.2% | $117.55M | +59.1% |
| 2024-09-30 | $0.13 | $0.15 | +15.4% | $119.84M | +78.1% |
| 2024-06-30 | $0.08 | $0.13 | +62.5% | $107.19M | +78.3% |
| 2024-03-31 | $0.06 | $0.08 | +33.3% | $81.88M | +43.9% |
| 2023-12-31 | $0.03 | $-0.08 | -366.7% | $73.90M | — |
| 2023-09-30 | $-0.01 | $0.01 | +200.0% | $67.28M | — |
| 2023-06-30 | $-0.02 | $-0.03 | -50.0% | $60.12M | — |
| 2023-03-31 | $-0.04 | $-0.03 | +25.0% | $56.91M | — |
Frequently asked questions
Has ADMA Biologics Inc beaten earnings estimates?
ADMA Biologics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -4.0% over the last 4 quarters.
How does ADMA stock react to earnings?
ADMA stock has moved an average of -6.5% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is ADMA Biologics Inc's revenue growth rate?
ADMA Biologics Inc reported year-over-year revenue growth of +18.4% in its most recent quarter, with EPS growing +58.6% year-over-year.